← All organizations

LUNGevity Foundation

Academic/HospitalWebsite ↗

Also known as: Lungevity Foundation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 1, 2023

Timeline

2000s

Jan 1, 2001
LUNGevity Foundation— Founded

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

alpha-methyl-4-deoxy-4-[(18)f]fluoro-d-glucopyranoside

Phase 1 (2 own, 0 via acquisition)

Recent trials (3)

NCT05558904CollaboratorPhase 1/Phase 2Jan 1, 2023
NCT05430009CollaboratorPhase 1Jun 17, 2022
NCT03546361CollaboratorPhase 1Sep 1, 2018

Details

Founded: Bethesda, MD, US Jan 1, 2001
Last known activity: Jan 1, 2023